PSMD11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.967600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.938400E-01
Normal-vs-Stage2
5.790800E-01
Normal-vs-Stage3
9.340800E-01
Normal-vs-Stage4
5.089600E-01
Stage1-vs-Stage2
2.579200E-01
Stage1-vs-Stage3
6.461000E-01
Stage1-vs-Stage4
6.711800E-01
Stage2-vs-Stage3
4.686400E-01
Stage2-vs-Stage4
8.843400E-01
Stage3-vs-Stage4
5.709600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.856400E-01
Normal-vs-AfricanAmerican
2.161200E-01
Normal-vs-Asian
3.000400E-01
Caucasian-vs-AfricanAmerican
2.177000E-01
Caucasian-vs-Asian
4.241400E-01
AfricanAmerican-vs-Asian
7.300000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.950400E-01
Normal-vs-Female
5.054200E-01
Male-vs-Female
7.743700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.618400E-01
Normal-vs-Age(41-60Yrs)
2.078600E-01
Normal-vs-Age(61-80Yrs)
7.598800E-01
Normal-vs-Age(81-100Yrs)
6.603200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.600200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.279200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.870600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.919860E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.427700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.090200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.564800E-01
Normal-vs-Daily Drinker
9.522800E-01
Normal-vs-Weekly Drinker
6.559400E-01
Normal-vs-Occasional Drinker
2.374000E-01
Normal-vs-Social Drinker
3.113400E-01
Non Drinker-vs-Daily Drinker
8.313600E-01
Non Drinker-vs-Weekly Drinker
2.232400E-01
Non Drinker-vs-Occasional Drinker
5.735800E-03
Non Drinker-vs-Social Drinker
1.682480E-02
Daily Drinker-vs-Weekly Drinker
3.795600E-01
Daily Drinker-vs-Occasional Drinker
9.279700E-03
Daily Drinker-vs-Social Drinker
5.824200E-02
Weekly Drinker-vs-Occasional Drinker
1.015980E-01
Weekly Drinker-vs-Social Drinker
3.401400E-01
Occasional Drinker-vs-Social Drinker
3.768000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.172200E-01
Normal-vs-Grade 2
3.195600E-01
Normal-vs-Grade 3
5.740800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.884210E-01
Grade 1-vs-Grade 3
2.008000E-02
Grade 1-vs-Grade 4
4.172200E-01
Grade 2-vs-Grade 3
4.896800E-01
Grade 2-vs-Grade 4
3.195600E-01
Grade 3-vs-Grade 4
5.740800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.773800E-01
Normal-vs-NonDiabetic
6.275200E-01
Diabetic-vs-NonDiabetic
2.842600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.922150E-01
Normal-vs-NoPancreatitis
6.925600E-01
Pancreatitis-vs-NoPancreatitis
3.475400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.816000E-01
Normal-vs-N1
5.847400E-01
N0-vs-N1
2.993800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.575840E-02
Normal-vs-TP53-NonMutant
9.020800E-01
TP53-Mutant-vs-TP53-NonMutant
7.014500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
